Chapter 4 - THE EXPERIMENT HIDDEN INSIDE HER MEDICAL FILE
Novacell Therapeutics was developing a cheaper substitute for Lily’s medication.
The company needed data from patients whose treatment had been interrupted.
No ethics board would approve such a study in children.
So Novacell created one secretly.
Daniel and Helen identified pediatric patients receiving the expensive drug.
They diverted doses.
They monitored relapses through altered hospital records.
Then Novacell compared each child’s deterioration against laboratory models.
Lily was Patient Seven.
Her collapse at school produced the most severe data set.
Inside the research file, her name had been replaced with a code.
P7-F.
AGE: 8.
PARENTAL COMPLIANCE: HIGH.
RISK OF INVESTIGATION: LOW.
The last line felt like another assault.
They believed I would obey doctors.
Trust Daniel.
Accept explanations.
My love for Lily had been recorded as a weakness in their risk assessment.
Margaret showed me the payment history.
Novacell sent Daniel more than nine hundred thousand dollars over eighteen months.
Vanessa received a smaller percentage.
Helen received monthly consulting fees.
Rebecca received nothing.
She was used for the most dangerous tasks because Daniel could control her through grief.
Detective Grant requested arrest warrants for Novacell executives.
The company’s legal department responded immediately.
They claimed Cole Patient Solutions provided anonymous pharmacy-market data.
They denied knowing children’s treatment had been interrupted.
Emails contradicted them.
One executive wrote:
P7 RESPONSE IS PROMISING. EXTEND INTERRUPTION UNTIL ORGAN MARKERS EXCEED BASELINE.
Daniel replied:
MOTHER IS BECOMING SUSPICIOUS. HUSBAND ACCESS REMAINS SUFFICIENT.
He referred to himself as though our marriage were a laboratory credential.
I read the message until the words blurred.
Then I stopped crying.
“Who wrote the executive email?”
Margaret enlarged the signature.
DR. ADRIAN VALE.
Chief medical officer.
The name sounded familiar.
Dr. Vale had attended Lily’s first specialist appointment.
He was not her physician.
He introduced himself as an observer from a patient-assistance foundation.
Daniel told me the foundation might cover medication costs.
In reality, Vale had been evaluating whether our family could be controlled.
I called my father, Samuel Pierce.
We had spoken rarely since my parents’ divorce.
He worked in venture finance and spent most of my childhood traveling.
When I mentioned Novacell, he became silent.
“Dad?”
“What did they do?”
I explained.
He asked one question.
“Is Adrian Vale involved?”
“Yes.”
My father arrived at the hospital two hours later with three attorneys.
He revealed that his investment firm had financed Novacell’s earliest research.
Five years earlier, he withdrew after discovering unexplained pediatric data.
The company assured him the information came from historical records.
He believed them.
“I should have investigated further,” he said.
“You left?”
“I sold the shares.”
“To whom?”
“A trust managed by Daniel.”
My husband had entered Novacell years before our daughter’s diagnosis.
He did not discover the research opportunity after Lily became sick.
He may have encouraged the medical testing that found her condition.
Her diagnosis gave him access to a live subject inside his own family.
“Did he marry me because of you?” I asked my father.
Samuel looked away.
Novacell wanted connections to his capital network.
Daniel met me at one of Samuel’s charity events.
Their relationship began before mine.
My marriage had been an investment strategy.
Lily’s illness turned it into an experiment.
Then Dr. Bennett entered.
He carried new imaging results.
Lily’s heart and kidneys showed inflammation, but treatment was beginning to work.
She remained critical.
Still, there was hope.
I touched her hand.
Her fingers moved slightly.
“Mom?”
The word was almost silent.
I leaned closer.
“I’m here.”
Her eyes opened for one second.
Then she whispered something I did not understand.
“The blue room.”
“What blue room?”
She lost consciousness again.
A nurse checked her.
Dr. Bennett looked concerned.
Lily had never mentioned a blue room before.
But investigators found photographs on Daniel’s phone showing her asleep inside a private clinic.
Blue walls.
No windows.
He had been taking our daughter somewhere while telling me she was at school.
May you like
Novacell had not only studied her hospital records.
They had performed procedures on her without my knowledge.
